29 April 2024 Joint Policy Statement regarding GLP-1/GIP Receptor Agonists in people living with obesity and/or type 2 diabetes Our policy statements set out our views on an important area in nutrition and may provide guidance to researchers, regulatory agencies and policy makers, health professionals, the food industry and the media. Policy Statement
